| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 09/19/1996 | WO1996028547A1 Dermatomyositis-specific auto-antigen |
| 09/19/1996 | WO1996028472A1 Antigen composition against mycoplasma |
| 09/19/1996 | WO1996028471A1 Modulators of amyloid aggregation |
| 09/19/1996 | WO1996028461A1 ISOLATED NUCLEIC ACID MOLECULES WHICH ARE MEMBERS OF THE MAGE-Xp FAMILY AND USES THEREOF |
| 09/19/1996 | WO1996028186A1 Use of g class immunoglobulins for the topical treatment of atopic dermatitis |
| 09/19/1996 | WO1996028177A1 Method and vaccine for prevention of over-production of acid in the rumen or gut of animals |
| 09/19/1996 | WO1996028176A1 Composition for oral tolerance induction and use thereof |
| 09/19/1996 | WO1996017936A3 Cloned porphyromonas gingivalis genes and probes for the detection of periodontal disease |
| 09/19/1996 | WO1995011008A3 Methods and compositions for microencapsulation of adjuvants |
| 09/19/1996 | CA2215383A1 Human tumor necrosis factor receptor |
| 09/19/1996 | CA2215016A1 Isolated nucleic acid molecules which are members of the mage-xp family and uses thereof |
| 09/18/1996 | EP0732402A2 Chimeric chains for receptor-associated signal transduction pathways |
| 09/18/1996 | EP0732340A2 Expression of porcine reproductive respiratory syndrome virus polypeptides in the same cell |
| 09/18/1996 | EP0732339A1 Peptides of the HIV-gag protein, their preparation and use |
| 09/18/1996 | EP0732104A1 Useful composition for the manufacture of vaccines containing particles bearing a hepatitis B virus surface antigen and polymerized human seric albumin receptor, animal cells able to produce such particles and process for their obtention |
| 09/18/1996 | EP0731915A1 Prenatal detection of meconium |
| 09/18/1996 | EP0731839A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition |
| 09/18/1996 | EP0731838A1 Binding structures directed against the ca55.1 antigen |
| 09/18/1996 | EP0731811A1 Chaperonin 10 |
| 09/18/1996 | EP0731712A1 Physiologically stable compositions of butyric acid, and butyric acid salts and derivatives as anti-neoplastic agents |
| 09/18/1996 | EP0731709A1 Novel neutrophil inhibitors |
| 09/18/1996 | EP0593625B1 Short-term anti-cd3 stimulation of lymphocytes to increase their in vivo activity |
| 09/18/1996 | EP0524958B1 Antigenic proteins of borrelia burgdorferi |
| 09/18/1996 | EP0482133B1 Use of lactoferrin to counter the toxic effects of endotoxins |
| 09/18/1996 | CN1131040A Preventing and curing agent for intestinal disease of chicken and its preparation method |
| 09/17/1996 | US5557033 Method of increasing egg production in avian species by active immunization against vasoactive intestinal peptide |
| 09/17/1996 | US5556946 Interleukin-2/viral antigen protein chimers |
| 09/17/1996 | US5556763 Patterns of transcription factors and lymphocytes |
| 09/17/1996 | US5556757 Peptides representing epitopic sites for bacterial and viral meningitis causing agents and their CNS carrier and uses thereof |
| 09/17/1996 | US5556755 Oligonucleotides and dna sequences |
| 09/17/1996 | US5556753 DNA encoding human α1 adrenegric receptors and uses thereof |
| 09/17/1996 | US5556625 Plant extracts as antimicrobial agents |
| 09/17/1996 | US5556624 Method of immunopotentiating and protecting an animal from E. coli infections using a combination of Rosa roxburghii, Artemisiae argyi folium and Brassica oleracea var. capitata L. |
| 09/17/1996 | US5556623 Inhibiting neoplasm growth in mammal by parenterally administering immunoconjugate of antibody or antigen-binding fragment thereof with beta-alanine whose amino is converted to drug derivative-substituted methylene amide |
| 09/16/1996 | CA2171881A1 Single-shot vaccine formulation |
| 09/12/1996 | WO1996027666A1 Novel avian cytokines and genetic sequences encoding same |
| 09/12/1996 | WO1996027610A1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon |
| 09/12/1996 | WO1996027603A1 Compositions and methods for the treatment and diagnosis of immune disorders |
| 09/12/1996 | WO1996027390A1 Compositions and methods for stimulating antibody class switching |
| 09/12/1996 | WO1996027389A1 Non-toxic immunogens derived from a retroviral regulatory protein, antibodies, preparation method therefor, and pharmaceutical compositions containing same |
| 09/12/1996 | WO1996027387A1 Identification of self and non-self antigens implicated in autoimmune disease |
| 09/12/1996 | WO1996020718A3 Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin |
| 09/12/1996 | WO1996012794A3 Isolated porcine pancreatic cells for use in treatment of diseases characterized by insufficient insulin activity |
| 09/12/1996 | CA2214726A1 Compositions and methods for stimulating antibody class switching |
| 09/12/1996 | CA2214589A1 Compositions and methods for the treatment and diagnosis of immune disorders |
| 09/12/1996 | CA2214453A1 Novel avian cytokines and genetic sequences encoding same |
| 09/12/1996 | CA2189738A1 Identification of self and non-self antigens implicated in autoimmune disease |
| 09/11/1996 | EP0731168A1 MSRV-1 virus and pathogenic and/or infectious agent MSRV-2 associated with rheumatoid arthritis |
| 09/11/1996 | EP0731167A1 Modular assembly of antibody genes, antibodies prepared thereby and use |
| 09/11/1996 | EP0731165A2 Human T-cell line infected with HIV-2 which secretes functionally intact HIV-2 GP160 |
| 09/11/1996 | EP0730657A1 Composition for the in vivo production of therapeutic products |
| 09/11/1996 | EP0730650A1 Retroviral superantigens, superantigen peptides, and methods of use |
| 09/11/1996 | EP0730648A1 HUMAN MUTATOR GENE hMSH2 AND HEREDITARY NON POLYPOSIS COLORECTAL CANCER |
| 09/11/1996 | EP0730647A1 Dna sequence coding for a bmp receptor |
| 09/11/1996 | EP0730646A1 PROTEIN TYROSINE KINASES NAMED Rse |
| 09/11/1996 | EP0730609A1 Recombinant il4 antibodies useful in treatment of il4 mediated disorders |
| 09/11/1996 | EP0534944B1 Antibodies specific for elam-1 and the use thereof |
| 09/11/1996 | EP0484401B1 Production of vascular endothelial cell growth factor |
| 09/11/1996 | EP0381719B1 Cellulose binding fusion proteins |
| 09/11/1996 | EP0372031B1 Biosynthetic osteogenic proteins and osteogenic devices containing them |
| 09/11/1996 | CN1130944A Diagnostic prognostic and therapeutic method for solid non-lymphoid tumors and their metastases |
| 09/11/1996 | CN1130923A Salmonella vaccines |
| 09/11/1996 | CN1130876A Compounds for prevention and treatment of helminth infections |
| 09/10/1996 | US5554724 Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses thereof |
| 09/10/1996 | US5554542 Immunoassay for isothiazolones |
| 09/10/1996 | US5554538 DNA sequences derived from papillomavirus HPV-33 genome |
| 09/10/1996 | US5554526 Human parainfluenza virus type 4A fusion protein and gene coding for the same |
| 09/10/1996 | US5554525 Chicken anemia virus vaccine and diagnostic |
| 09/10/1996 | US5554524 More complex type retroviruses having mixed type LTR, and uses thereof |
| 09/10/1996 | US5554506 Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
| 09/10/1996 | US5554501 Genetic analysis of patient samples |
| 09/10/1996 | US5554372 Methods and vaccines comprising surface-active copolymers |
| 09/10/1996 | US5554371 Contains antigenic recombinant polypeptide with amino acid sequence corresponding to that of recombinant polypeptide produced by e. coli transformant atcc 68825; immunization process |
| 09/10/1996 | CA2171242A1 Msrv-1 virus and pathogenic and/or infective msrv-2 related to rhumatoid arthritis |
| 09/08/1996 | CA2171144A1 Human t-cell line infected with hiv-2 which secretes functionally intact hiv-2 gp160 |
| 09/06/1996 | WO1996027013A1 Group o hiv-1, fragments of such viruses, and uses thereof |
| 09/06/1996 | WO1996027012A1 Specific hiv-1 group o antigens |
| 09/06/1996 | WO1996027011A1 A method for making heteromultimeric polypeptides |
| 09/06/1996 | WO1996027009A1 Human amine transporter |
| 09/06/1996 | WO1996027005A2 Recombinant dna molecules that code for polypeptides with antigenic properties of allergens clah8 and clah12 |
| 09/06/1996 | WO1996026964A1 Bispecific antibody effective to treat b-cell lymphoma and cell line |
| 09/06/1996 | WO1996026963A1 Antibodies active against a fusion polypeptide comprising a histidine portion |
| 09/06/1996 | WO1996026961A2 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use |
| 09/06/1996 | WO1996026741A1 Hepatitis b vaccine |
| 09/06/1996 | WO1996026740A1 Methods and compositions for production of customized vaccines for diseases associated with antigens of microorganisms |
| 09/06/1996 | WO1996026736A1 Vascular endothelial growth factor-b |
| 09/06/1996 | WO1996026735A1 Method for stimulating an immune response |
| 09/06/1996 | WO1996021015A3 Combination gene delivery vehicles |
| 09/06/1996 | WO1996021000A3 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |
| 09/06/1996 | WO1996020953A3 Synthetic multimeric peptide with delta hepatitis virus antigenic activity |
| 09/06/1996 | WO1996020277A3 Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen |
| 09/06/1996 | WO1996020219A3 Murine monoclonal anti-idiotype antibody 3h1 |
| 09/06/1996 | WO1996019965A3 Engraftment of hematopoietic cells from a primate donor to a primate recipient |
| 09/06/1996 | CA2247207A1 Peptidyl compounds comprising an itim motif which regulate hematopoietic function and their use |
| 09/06/1996 | CA2217186A1 Antibodies active against a fusion polypeptide comprising a histidine portion |
| 09/04/1996 | EP0729976A1 Reconstituted human antibody against human medulloblastomatous cell |
| 09/04/1996 | EP0729513A1 Analog of haemophilus hin47 with reduced protease activity |
| 09/04/1996 | EP0729511A1 Compositions and methods for utilizing conditionally lethal genes |
| 09/04/1996 | EP0729509A1 Vaccine against mumps containing a jeryl-lynn virus strain |
| 09/04/1996 | EP0729507A1 Method and composition for transfer of active tumor-specific immunization from an immunized allogeneic bone marrow donor |